Literature DB >> 35783623

Three-Dimensional Multi-Task Deep Learning Model to Detect Glaucomatous Optic Neuropathy and Myopic Features From Optical Coherence Tomography Scans: A Retrospective Multi-Centre Study.

An Ran Ran1,2, Xi Wang3,4, Poemen P Chan1,2,5, Noel C Chan1,6,7, Wilson Yip1,6,7, Alvin L Young1,6, Mandy O M Wong1,5, Hon-Wah Yung8, Robert T Chang9, Suria S Mannil9, Yih Chung Tham10,11,12, Ching-Yu Cheng10,11,12, Hao Chen13, Fei Li14, Xiulan Zhang14, Pheng-Ann Heng3, Clement C Tham1,2,5, Carol Y Cheung1,2.   

Abstract

Purpose: We aim to develop a multi-task three-dimensional (3D) deep learning (DL) model to detect glaucomatous optic neuropathy (GON) and myopic features (MF) simultaneously from spectral-domain optical coherence tomography (SDOCT) volumetric scans.
Methods: Each volumetric scan was labelled as GON according to the criteria of retinal nerve fibre layer (RNFL) thinning, with a structural defect that correlated in position with the visual field defect (i.e., reference standard). MF were graded by the SDOCT en face images, defined as presence of peripapillary atrophy (PPA), optic disc tilting, or fundus tessellation. The multi-task DL model was developed by ResNet with output of Yes/No GON and Yes/No MF. SDOCT scans were collected in a tertiary eye hospital (Hong Kong SAR, China) for training (80%), tuning (10%), and internal validation (10%). External testing was performed on five independent datasets from eye centres in Hong Kong, the United States, and Singapore, respectively. For GON detection, we compared the model to the average RNFL thickness measurement generated from the SDOCT device. To investigate whether MF can affect the model's performance on GON detection, we conducted subgroup analyses in groups stratified by Yes/No MF. The area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, and accuracy were reported.
Results: A total of 8,151 SDOCT volumetric scans from 3,609 eyes were collected. For detecting GON, in the internal validation, the proposed 3D model had significantly higher AUROC (0.949 vs. 0.913, p < 0.001) than average RNFL thickness in discriminating GON from normal. In the external testing, the two approaches had comparable performance. In the subgroup analysis, the multi-task DL model performed significantly better in the group of "no MF" (0.883 vs. 0.965, p-value < 0.001) in one external testing dataset, but no significant difference in internal validation and other external testing datasets. The multi-task DL model's performance to detect MF was also generalizable in all datasets, with the AUROC values ranging from 0.855 to 0.896.
Conclusion: The proposed multi-task 3D DL model demonstrated high generalizability in all the datasets and the presence of MF did not affect the accuracy of GON detection generally.
Copyright © 2022 Ran, Wang, Chan, Chan, Yip, Young, Wong, Yung, Chang, Mannil, Tham, Cheng, Chen, Li, Zhang, Heng, Tham and Cheung.

Entities:  

Keywords:  artificial intelligence; deep learning; glaucoma; glaucomatous optic neuropathy; multi-task; myopia; myopic features; optical coherence tomography

Year:  2022        PMID: 35783623      PMCID: PMC9240220          DOI: 10.3389/fmed.2022.860574

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  44 in total

1.  Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: interpreting the RNFL maps in healthy myopic eyes.

Authors:  Christopher Kai-Shun Leung; Marco Yu; Robert N Weinreb; Heather Kayew Mak; Gilda Lai; Cong Ye; Dennis Shun-Chiu Lam
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-17       Impact factor: 4.799

2.  Association between myopia and glaucoma in the United States population.

Authors:  Mary Qiu; Sophia Y Wang; Kuldev Singh; Shan C Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-28       Impact factor: 4.799

Review 3.  Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis.

Authors:  Michael W Marcus; Margriet M de Vries; Francisco G Junoy Montolio; Nomdo M Jansonius
Journal:  Ophthalmology       Date:  2011-10       Impact factor: 12.079

4.  Hybrid Deep Learning on Single Wide-field Optical Coherence tomography Scans Accurately Classifies Glaucoma Suspects.

Authors:  Hassan Muhammad; Thomas J Fuchs; Nicole De Cuir; Carlos G De Moraes; Dana M Blumberg; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  J Glaucoma       Date:  2017-12       Impact factor: 2.503

5.  High myopia and glaucoma susceptibility the Beijing Eye Study.

Authors:  Liang Xu; Yaxing Wang; Shuang Wang; Yun Wang; Jost B Jonas
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

6.  A Deep Learning Algorithm to Quantify Neuroretinal Rim Loss From Optic Disc Photographs.

Authors:  Atalie C Thompson; Alessandro A Jammal; Felipe A Medeiros
Journal:  Am J Ophthalmol       Date:  2019-01-26       Impact factor: 5.258

Review 7.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

Authors:  Yih-Chung Tham; Xiang Li; Tien Y Wong; Harry A Quigley; Tin Aung; Ching-Yu Cheng
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

8.  Sensitivity and specificity of time-domain versus spectral-domain optical coherence tomography in diagnosing early to moderate glaucoma.

Authors:  Robert T Chang; O'Rese J Knight; William J Feuer; Donald L Budenz
Journal:  Ophthalmology       Date:  2009-10-02       Impact factor: 12.079

9.  Associations between Optic Nerve Head-Related Anatomical Parameters and Refractive Error over the Full Range of Glaucoma Severity.

Authors:  Neda Baniasadi; Mengyu Wang; Hui Wang; Mufeed Mahd; Tobias Elze
Journal:  Transl Vis Sci Technol       Date:  2017-07-18       Impact factor: 3.283

10.  Development of a deep residual learning algorithm to screen for glaucoma from fundus photography.

Authors:  Naoto Shibata; Masaki Tanito; Keita Mitsuhashi; Yuri Fujino; Masato Matsuura; Hiroshi Murata; Ryo Asaoka
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.